Ledger.Open graph →
SEC Form D · filed December 29, 2017

ENDONOVO THERAPEUTICS, INC

Offering
$8.0M
Sold
$700K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
WOODLAND HILLS, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (5)

Robert Gilbreath · Cincinnati, OHExec · DirectorMichael Mann · Woodland Hills, CAExecSteve K. Kooper · Sugar Land, TXExec · DirectorMichael F. Johnson · Vista, CAExecAlan Collier · Woodland Hills, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗